In a recent interview with the BBC, Alex Eades discussed an innovative mutation detection programme. This groundbreaking method allows for the monitoring of tumours at Kings College Hospital, London, without the need for tissue removal. It is capable of identifying a single molecule among 10,000 to 100,000, empowering oncologists to assess the effectiveness of surgeries or therapies. The video of the interview is available for viewing.